ABOUT THIS FUND
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
PRICE
$13.53 ▲ UP 48.35% (+$73.38)—
No price history available for CHNA over this range.
HOLDINGS
TOP 4 OF 4 · 6.63% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
